CSIMarket


Coeptis Therapeutics Holdings Inc   (COEP)
Other Ticker:  
 


 

Coeptis Therapeutics Holdings Inc

COEP's Financial Statements and Analysis



Coeptis Therapeutics Holdings Inc reported III. Quarter net loss per share of $-0.06 compare to earnings per share of $0.45 in the same quarter a year ago a decrease compare to $-0.03 realized in previous quarter.


III. Quarter
Earnings Per Share Revenues
$ -0.06 $  0 Mill
$-0.51     Unch.    



Coeptis Therapeutics Holdings Inc 's Revenue fell by 0 % in III. Quarter (Sep 30 2022) year on year, to $0 million and declined by sequentially.


Coeptis Therapeutics Holdings Inc is Expected to report next financial results on November 17, 2023.

More on COEP's Income Statement



Coeptis Therapeutics Holdings Inc 's in III. Quarter recorded net loss of $-0.305 million, compare to net income of $4.177 million achieved in III. Quarter a year ago.

Sequentially net loss advanced

More on COEP's Growth

In III. Quarter company's net cash and cash equivalents decreased by $0 million


Coeptis Therapeutics Holdings Inc does not pay out common stock dividend.

In trailing twelve-month period Coeptis Therapeutics Holdings Inc payed $ -0.23 cash per share, on a free-cash flow basis .